Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Dobutamine on the Cardiac Conduction System: Site-Specific Dose

NCT04249258 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT04249258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04249258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Dobutamine on the Cardiac Conduction System: Site-Specific Dose
Lead sponsor
Northwell Health
Phase
Phase 1
Overall status
Completed
Start date
January 14, 2020
Completion date
November 20, 2021
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac